Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
about
Immunohistochemical expression of vascular endothelial growth factor in orofacial lesions - A reviewTranscatheter Arterial Embolization Alone for Giant Hepatic Hemangioma.Sclerosed Hemangioma Accompanied by Multiple Cavernous Hemangiomas of the Liver.Management of airway hemangiomas.Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells.Metastatic Renal Cell Carcinoma in a Hepatic Hemangioma: A Case Report and Review of the Literature.Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas.Vascular endothelial growth factor expression and pathological changes in the local tissue of facial hemangiomas following injections with pure alcohol.Giant cavernous hepatic hemangioma shrunk by use of sorafenib.Uncommon evolutions and complications of common benign liver lesions.Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas.Hepatic Hemangiomas Alter Morphometry and Impair Hemodynamics of the Abdominal Aorta and Primary Branches From Computer Simulations.Risk factors for hemoglobinuria after ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous hemangiomas.
P2860
Q28066284-9D81C04B-4D8E-4CC0-B5AD-5A9D1E02868EQ30404136-C57129FA-B591-4CA0-AD90-32C786CEF3EEQ35798519-7AD57306-821F-4464-AF28-6D04FBDD6423Q37775621-EA0DA405-9AD8-403B-BE01-65CB462F9852Q38667341-AD0BBD77-784E-4E42-BBAB-D45804033623Q38749120-D21DE28D-56F2-4A35-A2BE-C411D0FA6B02Q40055287-BA2F7BB7-6651-4D6E-8B9E-2E9057595D64Q42549450-9091FEA2-DD02-4FE3-9482-7E541FB91754Q43159026-B738C7AA-2068-4F24-BB1C-31B3E3CE50CAQ48089820-C957E5A7-7DEE-4E04-B0EA-A12DC5BE0D96Q50100518-E4890792-1B92-4002-A700-65B2DB86D3BEQ55311437-1B7D3272-505A-4C07-AC79-0101294856C5Q55442885-031A354E-AF87-422F-A9EC-545C11ED92BF
P2860
Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@en
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@nl
type
label
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@en
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@nl
prefLabel
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@en
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@nl
P2093
P1476
Incidental reduction in the si ...... of VEGF inhibitor bevacizumab.
@en
P2093
Arthur McCullough
Charles Miller
Dipti Mahajan
Kenzo Hirose
Lisa Yerian
P304
P356
10.1016/J.JHEP.2008.06.028
P577
2008-08-21T00:00:00Z